Today: 20 May 2026
AI stocks jump as Meta’s Corning deal hits “plumbing” plays; CoreWeave extends Nvidia bump
27 January 2026
2 mins read

AI stocks jump as Meta’s Corning deal hits “plumbing” plays; CoreWeave extends Nvidia bump

New York, Jan 27, 2026, 10:25 EST — Regular session

  • Corning surged 12.9%, while CoreWeave climbed 8.5% amid a rush into AI data-center supply chain stocks.
  • Micron jumped 4.8%, with Nvidia, AMD, and Broadcom gaining roughly 1% to 2% in early trading.
  • Meta dipped 0.7% ahead of its earnings report scheduled for Wednesday.

Corning shares surged to $107.18, with CoreWeave gaining ground at $106.65 on Tuesday, leading a group of AI-related stocks that have been acting as a proxy for data-center expansion bets. Nvidia ticked up 1.0%, while AMD and Broadcom each advanced roughly 1.5%; Micron outpaced them all. Meta shares slipped.

The market is focused on distinguishing “AI demand” from “AI bills” at this moment. Traders are zeroing in on where the spending hits — cables, chips, memory, and the equipment used to produce them — as a packed earnings week sheds new light on spending strategies.

Meta announced plans to pay Corning as much as $6 billion over the coming years to provide fiber-optic cables and connectivity equipment for its AI data centers. Corning will boost its production capacity in North Carolina. CEO Wendell Weeks described the move as an effort to “strengthen domestic supply chains,” according to statements released alongside the deal. Reuters

CoreWeave’s shares jumped after Nvidia revealed a $2 billion stake on Monday, making the chip giant the AI cloud provider’s second-largest backer, according to Reuters. The company, part of the so-called “neoclouds” that lease high-end AI chips, said the funding will support securing land and power as it aims for over 5 gigawatts of data-center capacity by 2030. CEO Michael Intrator described the move as proof of “the strength of demand” CoreWeave is experiencing. Reuters

Micron announced plans to invest $24 billion in a chip manufacturing facility in Singapore over the next ten years, targeting a relief in memory shortages driven by AI demand. The company expects wafer production to kick off in the latter half of 2028. Alongside this, Micron is constructing a $7 billion high-bandwidth memory (HBM) packaging plant in Singapore, slated to begin output in 2027. HBM is a memory type stacked close to AI processors to enhance data transfer speeds. TrendForce analyst Bryan Ao warned that enterprise solid-state drive contract prices could surge 55% to 60%, as demand continues to outpace supply.

In Europe, investors are zeroing in on ASML, the Dutch company that leads in extreme ultraviolet (EUV) lithography — the chip “printer” essential for cutting-edge semiconductors. Analysts told Reuters that all eyes will be on Wednesday’s earnings report to see if ASML raises its 2026 guidance. John West of the consultancy Yole Group described EUV as “the only game in town.” Reuters

Big Tech earnings hit the spotlight this week, with Microsoft and Meta set to report on Wednesday. Investors want proof that their hefty spending is driving real growth. Reuters noted that Microsoft, Meta, and Amazon plan to boost their AI budgets by 30%, pushing total investment past $500 billion this year. David Wagner, head of equities at Aptus Capital Advisors, warned that “proprietary ecosystems” remain tough to penetrate as the focus shifts from flashy demos to actual distribution and cash flow. Reuters

That said, the trade has its vulnerabilities: budgets often climb faster than revenue, and physical limits are tangible. Power, networking equipment, and memory may all create bottlenecks, with any slip in guidance likely to hit the high-multiple stocks hardest.

Wednesday brings a triple whammy: Meta and Microsoft report in the U.S., while ASML delivers its update from Europe. Investors will zero in on capex plans and fresh clues about capacity — who’s ready to ship, and on what timeline.

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
USBC stock jumps in premarket after Uphold, Vast Bank tokenized-deposit deal
Previous Story

USBC stock jumps in premarket after Uphold, Vast Bank tokenized-deposit deal

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps
Next Story

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Go toTop